サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1511931

インスリンペンの市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2024年～2030年

Insulin Pens Market Size, Share & Trends Analysis Report By Type (Reusable Insulin Pens, Disposable Insulin Pens), By End-use (Hospitals & Clinics, Homecare, Others), By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
インスリンペンの市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2024年～2030年
出版日: 2024年06月20日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

インスリンペン市場の成長と動向：

Grand View Research社の最新レポートによると、世界のインスリンペン市場規模は2030年までに124億1,000万米ドルに達すると予測されています。

予測期間である2024年から2030年にかけてのCAGRは8.08%で拡大すると予測されています。市場成長を促進する主な要因としては、世界の糖尿病有病率の上昇が挙げられます。国際糖尿病連合によると、2021年には約5億3,700万人の成人が糖尿病患者であったが、2030年には6億4,300万人に増加すると予想されています。この増加する数字は、インスリン・ペンのような効果的で便利なインスリン送達方法に対する需要を著しく煽っています。

国際協定は、2025年までに糖尿病と肥満の増加を食い止めることを目標としています。現在、世界の糖尿病人口約4億2,200万人の大半は低所得国に居住しており、2型糖尿病による年間150万人の死亡に寄与しています。ここ数十年、糖尿病罹患率は着実に増加しています。IDF糖尿病アトラスの最新データによると、世界の糖尿病有病率は10.5％で、44.7％近くが未診断のままです。IDFの将来予測によると、2045年までに糖尿病を患う成人の数は7億8,300万人に達する可能性があり、これは世界人口のおよそ12.5%に相当し、46%の増加となります。この増加傾向は、同時期に予想される世界人口の増加率20％を大きく上回る。

インスリン・ペン技術の進歩、老年人口の増加、様々な地域におけるヘルスケア・インフラへの投資の増加が、市場拡大において極めて重要です。さらに、従来のシリンジやバイアルよりも最新のインスリン送達デバイスへのシフトが、市場拡大に極めて重要な役割を果たしています。しかし、市場はインスリンペン治療に伴う高コストや新興国における償還政策の制限といった課題に直面しています。こうした障害にもかかわらず、革新的で費用対効果の高いインスリンペンを導入するための研究開発が進められており、こうしたハードルを克服することが期待されています。

インスリンペンの世界市場レポートハイライト

  • タイプ別では、インスリンペン市場は使い捨てと再利用可能なインスリンペンに分類され、その利便性と衛生上の利点から使い捨てペンが最大の市場シェアを占めています。
  • 最終用途別では、インスリンペン市場は病院＆クリニック、在宅ケア、その他に区分されます。このうち、在宅ケア分野は2023年に48.21％の最大市場シェアを獲得しました。
  • さらに、北米のインスリンペン市場は、確立された医療インフラ、高い糖尿病有病率、大手市場プレイヤーの強力な存在感により、2023年に40.73％の最高収益シェアを獲得し、市場を独占しました。
  • アジア太平洋地域は、予測期間中に8.8％の最速成長率（CAGR）すると予想され、医療支出の増加、糖尿病意識の高まり、中国やインドなどの新興経済国におけるヘルスケア施設の改善に牽引されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 インスリンペン市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • インスリンペン市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 インスリンペン市場：タイプ推定・動向分析

  • セグメントダッシュボード
  • 世界のインスリンペン型市場変動分析
  • 世界のインスリンペン市場規模と動向分析、タイプ別、2018年～2030年
  • 再利用可能インスリンペン
  • 使い捨てインスリンペン

第5章 インスリンペン市場：最終用途の推定・動向分析

  • セグメントダッシュボード
  • 世界のインスリンペン最終用途市場変動分析
  • 世界のインスリンペン市場規模と動向分析、最終用途別、2018年～2030年
  • 病院・クリニック
  • ホームケア
  • その他

第6章 インスリンペン市場：製品、用途、モダリティ、最終用途別の地域推定・動向分析

  • 地域別市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 世界地域市場スナップショット
  • 市場規模、予測動向分析、2018年～2030年
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • 主要企業の市場シェア分析、2023年
  • Company Position Analysis
  • 企業分類（新興企業、イノベーター、リーダー）
  • 企業プロファイル
    • Medtronic Plc
    • Novo Nordisk A/S
    • Sanofi
    • Eli Lilly and Company
    • Ypsomed AG
    • Insulet Corporation
    • B. Braun SE
    • Owen Mumford Ltd.
    • Tandem Diabetes Care, Inc.
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America insulin pens market, By country, 2018 - 2030 (USD Million)
  • Table 4 North America insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 5 North America insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 7 U.S. insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 8 Canada insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 9 Canada insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 10 Mexico insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 11 Mexico insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe insulin pens market, By country, 2018 - 2030 (USD Million)
  • Table 13 Europe insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 14 Europe insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 15 UK insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 16 UK insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 17 Germany insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 18 Germany insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 19 France insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 20 France insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 21 Italy insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 22 Italy insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 23 Denmark insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 24 Denmark insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 25 Sweden insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 26 Sweden insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 27 Norway insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 28 Norway insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific insulin pens market, By country, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 32 Japan insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 33 Japan insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 34 China insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 35 China insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 36 India insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 37 India insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 38 Australia insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 39 Australia insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 40 South Korea insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 41 South Korea insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 42 Thailand insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 43 Thailand insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 44 Latin America insulin pens market, By Country, 2018 - 2030 (USD Million)
  • Table 45 Latin America insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 46 Latin America insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 47 Brazil insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 48 Brazil insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 49 Argentina insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 50 Argentina insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 51 Middle East & Africa insulin pens market, By country, 2018 - 2030 (USD Million)
  • Table 52 Middle East & Africa insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 53 Middle East & Africa insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 54 South Africa insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 55 South Africa insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 56 Saudi Arabia insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 58 UAE insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 59 UAE insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 60 Kuwait insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 61 Kuwait insulin pens market, By end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Insulin pens market: market outlook
  • Fig. 14 Parent market outlook
  • Fig. 15 Related/ancillary market outlook
  • Fig. 16 Penetration and growth prospect mapping
  • Fig. 17 Industry value chain analysis
  • Fig. 18 Insulin pens market driver impact
  • Fig. 19 Insulin pens market restraint impact
  • Fig. 20 Insulin pens market: Type movement analysis
  • Fig. 21 Insulin pens market: Type outlook and key takeaways
  • Fig. 22 Reusable insulin pens market estimates and forecast, 2018 - 2030
  • Fig. 23 Disposable insulin pens market estimates and forecast, 2018 - 2030
  • Fig. 24 Insulin pens market: End use movement analysis
  • Fig. 25 Insulin pens market: End use outlook and key takeaways
  • Fig. 26 Hospitals and clinics market estimates and forecast, 2018 - 2030
  • Fig. 27 Homecare market estimates and forecast, 2018 - 2030
  • Fig. 28 Others end users market estimates and forecast, 2018 - 2030
  • Fig. 29 Global insulin pens market: Regional movement analysis
  • Fig. 30 Global insulin pens market: Regional outlook and key takeaways
  • Fig. 31 North America
  • Fig. 32 North America market estimates and forecasts, 2018 - 2030
  • Fig. 33 U.S.
  • Fig. 34 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 35 Canada
  • Fig. 36 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 37 Mexico
  • Fig. 38 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 39 Europe
  • Fig. 40 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 41 UK
  • Fig. 42 UK market estimates and forecasts, 2018 - 2030
  • Fig. 43 Germany
  • Fig. 44 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 45 France
  • Fig. 46 France market estimates and forecasts, 2018 - 2030
  • Fig. 47 Italy
  • Fig. 48 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 49 Spain
  • Fig. 50 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 51 Denmark
  • Fig. 52 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 53 Sweden
  • Fig. 54 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 55 Norway
  • Fig. 56 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 57 Asia Pacific
  • Fig. 58 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 59 China
  • Fig. 60 China market estimates and forecasts, 2018 - 2030
  • Fig. 61 Japan
  • Fig. 62 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 63 India
  • Fig. 64 India market estimates and forecasts, 2018 - 2030
  • Fig. 65 Thailand
  • Fig. 66 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 67 South Korea
  • Fig. 68 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 69 Australia
  • Fig. 70 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 71 Latin America
  • Fig. 72 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 73 Brazil
  • Fig. 74 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 75 Mexico
  • Fig. 76 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 77 Argentina
  • Fig. 78 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 79 Middle East and Africa
  • Fig. 80 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 81 South Africa
  • Fig. 82 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 83 Saudi Arabia
  • Fig. 84 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 85 UAE
  • Fig. 86 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 87 Kuwait
  • Fig. 88 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 89 Market share of key market players- Insulin pens market
目次
Product Code: GVR-4-68040-302-6

Insulin Pens Market Growth & Trends:

The global insulin pens market size is anticipated to reach USD 12.41 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 8.08% during the forecast period, 2024 to 2030. Key drivers propelling market growth include rising prevalence of diabetes worldwide. According to the International Diabetes Federation, approximately 537 million adults were living with diabetes in 2021, a number expected to rise to 643 million by 2030. This escalating figure has significantly fueled the demand for effective and convenient insulin delivery methods, such as insulin pens.

The international agreement aims to stop the rise of diabetes and obesity by 2025. Currently, the majority of the global diabetic population of approximately 422 million resides in lower-income countries, contributing to 1.5 million deaths annually due to type 2 diabetes. Over recent decades, there has been a steady increase in diabetes rates. The latest data from the IDF Diabetes Atlas indicates a global diabetes prevalence rate of 10.5%, with nearly 44.7% of cases remaining undiagnosed. Future forecasts from the IDF suggest that by 2045, the number of adults with diabetes could reach 783 million, or roughly 12.5% of the global population, marking a 46% increase. This uptrend significantly outpaces the anticipated global population growth of 20% for the same timeframe.

Advancements in insulin pen technology, the growing geriatric population, and increasing investments in healthcare infrastructure across various regions have been crucial in market expansion. Furthermore, the shift towards modern insulin delivery devices over traditional syringes and vials has played a pivotal role in market expansion. However, the market faces challenges such as high costs associated with insulin pen therapy and limited reimbursement policies in developing countries. Despite these barriers, ongoing research and development efforts to introduce innovative, cost-effective insulin pens are anticipated to overcome these hurdles.

Global Insulin Pens Market Report Highlights:

  • By type, the insulin pens market is categorized into disposable and reusable insulin pens, with disposable pens holding the largest market share due to their convenience and hygiene benefits
  • By end use, the insulin pens market is segmented into hospitals & clinics, homecare, and others. Among these, homecare segment captured the largest market share of 48.21% in 2023
  • Furthermore, North America insulin pens market dominated the market by capturing the highest revenue share of 40.73% in 2023 owing to its well-established healthcare infrastructure, high diabetes prevalence, and strong presence of leading market players
  • The Asia Pacific region is expected to witness the fastest growth rate (CAGR) of 8.8% during the forecast period, driven by increasing healthcare expenditure, rising diabetes awareness, and improving healthcare facilities in emerging economies such as China and India

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Insulin Pens Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rise in the prevalence of diabetes globally
      • 3.2.1.2. Advancements in technology and development of smart insulin pens
      • 3.2.1.3. Growing awareness and education about diabetes management
      • 3.2.1.4. Increasing government initiatives and support to provide accessible and affordable diabetes treatment
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of smart insulin pens
      • 3.2.2.2. Lack of awareness and education about advanced diabetes management tools
      • 3.2.2.3. Stringent regulatory approvals
  • 3.3. Insulin Pens Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Insulin Pens Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Insulin Pens Type Market Movement Analysis
  • 4.3. Global Insulin Pens Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Reusable Insulin Pens
    • 4.4.1. Reusable insulin pens market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Disposable Insulin Pens
    • 4.5.1. Disposable insulin pens market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Insulin Pens Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Insulin Pens End Use Market Movement Analysis
  • 5.3. Global Insulin Pens Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals & Clinics
    • 5.4.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Homecare
    • 5.5.1. Homecare market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Insulin Pens Market: Regional Estimates & Trend Analysis By Product , Application, Modality, End Use

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Competitive scenario
      • 6.5.1.3. Regulatory framework
      • 6.5.1.4. Reimbursement structure
      • 6.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Reimbursement structure
      • 6.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Competitive scenario
      • 6.5.3.3. Regulatory framework
      • 6.5.3.4. Reimbursement structure
      • 6.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Competitive scenario
      • 6.6.1.3. Regulatory framework
      • 6.6.1.4. Reimbursement structure
      • 6.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement structure
      • 6.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement structure
      • 6.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Competitive scenario
      • 6.6.4.3. Regulatory framework
      • 6.6.4.4. Reimbursement structure
      • 6.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Competitive scenario
      • 6.6.5.3. Regulatory framework
      • 6.6.5.4. Reimbursement structure
      • 6.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Competitive scenario
      • 6.6.6.3. Regulatory framework
      • 6.6.6.4. Reimbursement structure
      • 6.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Competitive scenario
      • 6.6.7.3. Regulatory framework
      • 6.6.7.4. Reimbursement structure
      • 6.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Competitive scenario
      • 6.6.8.3. Regulatory framework
      • 6.6.8.4. Reimbursement structure
      • 6.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement structure
      • 6.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement structure
      • 6.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement structure
      • 6.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement structure
      • 6.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement structure
      • 6.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Competitive scenario
      • 6.7.6.3. Regulatory framework
      • 6.7.6.4. Reimbursement structure
      • 6.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Competitive scenario
      • 6.8.1.3. Regulatory framework
      • 6.8.1.4. Reimbursement structure
      • 6.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Competitive scenario
      • 6.8.2.3. Regulatory framework
      • 6.8.2.4. Reimbursement structure
      • 6.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Competitive scenario
      • 6.9.1.3. Regulatory framework
      • 6.9.1.4. Reimbursement structure
      • 6.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Competitive scenario
      • 6.9.2.3. Regulatory framework
      • 6.9.2.4. Reimbursement structure
      • 6.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Competitive scenario
      • 6.9.3.3. Regulatory framework
      • 6.9.3.4. Reimbursement structure
      • 6.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Competitive scenario
      • 6.9.4.3. Regulatory framework
      • 6.9.4.4. Reimbursement structure
      • 6.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Key company market share analysis, 2023
  • 7.4. Company Position Analysis
  • 7.5. Company Categorization (Emerging Players, Innovators and Leaders
  • 7.6. Company Profiles
    • 7.6.1. Medtronic Plc
      • 7.6.1.1. Company overview
      • 7.6.1.2. Financial performance
      • 7.6.1.3. Product benchmarking
      • 7.6.1.4. Strategic initiatives
    • 7.6.2. Novo Nordisk A/S
      • 7.6.2.1. Company overview
      • 7.6.2.2. Financial performance
      • 7.6.2.3. Product benchmarking
      • 7.6.2.4. Strategic initiatives
    • 7.6.3. Sanofi
      • 7.6.3.1. Company overview
      • 7.6.3.2. Financial performance
      • 7.6.3.3. Product benchmarking
      • 7.6.3.4. Strategic initiatives
    • 7.6.4. Eli Lilly and Company
      • 7.6.4.1. Company overview
      • 7.6.4.2. Financial performance
      • 7.6.4.3. Product benchmarking
      • 7.6.4.4. Strategic initiatives
    • 7.6.5. Ypsomed AG
      • 7.6.5.1. Company overview
      • 7.6.5.2. Financial performance
      • 7.6.5.3. Product benchmarking
      • 7.6.5.4. Strategic initiatives
    • 7.6.6. Insulet Corporation
      • 7.6.6.1. Company overview
      • 7.6.6.2. Financial performance
      • 7.6.6.3. Product benchmarking
      • 7.6.6.4. Strategic initiatives
    • 7.6.7. B. Braun SE
      • 7.6.7.1. Company overview
      • 7.6.7.2. Financial performance
      • 7.6.7.3. Product benchmarking
      • 7.6.7.4. Strategic initiatives
    • 7.6.8. Owen Mumford Ltd.
      • 7.6.8.1. Company overview
      • 7.6.8.2. Financial performance
      • 7.6.8.3. Product benchmarking
      • 7.6.8.4. Strategic initiatives
    • 7.6.9. Tandem Diabetes Care, Inc.
      • 7.6.9.1. Company overview
      • 7.6.9.2. Financial performance
      • 7.6.9.3. Product benchmarking
      • 7.6.9.4. Strategic initiatives